CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS

Aim. Hospital-based economic analysis for the use of thrombopoietin receptor agonists (TRA) Eltrombopag and Romiplostim has been performed in patients with chronic idiopathic thrombocytopenic purpura (ITP) at the background failure of previous treatment options. Materials and methods. Two models for...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: E. A. Pyadushkina, M. Yu. Frolov, M. V. Avksentyeva
Formato: Artigo
Lenguaje:Russo
Publicado: IRBIS LLC 2016-02-01
Colección:Фармакоэкономика
Materias:
idiopathic thrombocytopenic purpura (itp)
cost-minimization analysis
budget impact analysis
thrombopoietin receptor agonist (tpo-ra)
eltrombopag
romiplostim
Acceso en línea:https://www.pharmacoeconomics.ru/jour/article/view/130
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares